Portage Biotech Inc. (NASDAQ:ATON – Get Free Report)’s stock price shot up 3.8% on Tuesday . The stock traded as high as $0.3504 and last traded at $0.3320. 9,777,470 shares changed hands during mid-day trading, an increase of 209% from the average daily volume of 3,165,393 shares. The stock had previously closed at $0.32.
Portage Biotech Stock Performance
The business has a 50 day moving average of $0.33. The stock has a market cap of $7.78 million, a P/E ratio of -0.04 and a beta of 0.49.
Portage Biotech Company Profile
Portage Biotech (NASDAQ:ATON) is a biotechnology company focused on acquiring, developing and advancing therapeutic candidates and platform technologies. The company concentrates its development efforts primarily in areas such as oncology, immunology/inflammation and infectious disease, seeking to move programs from discovery and preclinical stages into clinical development through subsidiary companies and collaborative arrangements.
Portage structures its operations to support a diversified pipeline, advancing both small molecules and biologics by funding preclinical research, conducting clinical trials, and managing regulatory interactions.
Further Reading
- Five stocks we like better than Portage Biotech
- Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Street
- Revving Up Returns: Big Banks Race Through the Rate Plateau
- Why Uber’s Biggest Deal Yet Could Unlock Its Next Growth Phase
- Why Microsoft Is Playing a Different AI Game Than Big Tech—and Cash Flow Is the Test
Receive News & Ratings for Portage Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Portage Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
